1 Data on drug prescriptions were obtained from the general practitioners of 196 women who had had infants with clefts of lip or palate and those of 407 control women, matched for age, parity, social class and year of delivery.
2 There was no excess of index women who had presented with nausea or vomiting.
3 There was a significant excess (12 cases, nine controls, P<0.02) of women who had been prescribed Debendox (the 3-constituent, or pre-1976, formulation of Bendectin) in early pregnancy.
4 This result was not thought to be conclusive evidence of a teratogenic effect but caution in prescribing is advised pending more extensive studies.
Get full access to this article
View all access options for this article.
References
1.
Acheson, E.D. (1967). Medical Record Linkage. London , University Press.
2.
Baldwin, J.A. (1972). The Oxford Record Linkage Study as a Medical Information System. Proceedings of the Royal Society of Medicine., 65, 237-246.
3.
Donnai, D. & Harris, R. (1978) Unusual fetal malformations after antiemetics in early pregnancy. Brit. Med. J., 691-692.
4.
Fitzgerald, M.J.T. (1978) Human Embryology. Maryland, Harper International.
Harron, D.W.G., Griffiths, K. & Shanks, R.G. (1980). Debendox and congenital malformations in Northern Ireland. Brit. Med. J., 281,1379-1381.
7.
Hook, E.B. (1974). Nausea and vomiting of pregnancy diminishes maternal smoking—is it a general feto-protective mechanism against human embryo toxins?Teratology. A21.
8.
Mellow, S. (1978). Fetal malformation after Debendox treatment in early pregnancy. Brit. Med. J., 11, 1055-1056.
9.
Milkovich, L. & Berg, Van Den B. J. (1976). An evaluation of the teratogenicity of certain antinauseant drugs. Am. J. Obstet. Gynecol.,125, 244-248.
10.
Nelson, M.N. & Forfar, J.O. (1971). Associations between drugs administered during pregnancy and congenital abnormalities of the foetus. Brit. Med. J., 1,523-527.
11.
Newman, N.M., Correy, J.F. & Dudgeon, G.I. (1977). A survey of congenital abnormalities and drugs in private practice. Aust. N. Z. J. Gynaecol., 17, 156.
Pike, M.C. & Morrow, R.H. (1970). Statistical analysis of patient-control studies in epidemiology. Brit. J. Prev. Soc. Med., 24, 42-44.
14.
Richards, I.D.G. (1972). A retrospective enquiry into possible teratogenic effects of drugs in pregnancy. In Drugs and Fetal Development. Advances in Experimental Medicine and Biology. eds Klingberg, M. A., Abramovic, A., & Chembe, J.Plenum Press . 27,411-455.
15.
Rosenzweig, S. & Blaustein, F.M. (1970). Cleft palate in A/J mice resulting from restraint and deprivation of food and water. Teratology, 3, 47-52.
16.
Rothman, K.J., Flyer, D.C., Goldblatt, A. & Kreidberg, M.B. (1979). Exogenous hormones and other drug exposures of children with congenital heart disease. Am. J. Epid., 109, 433-439.
17.
Saxen I. (1975a). Epidemiology of Cleft Lip and Palate. Brit. J. Prev. Soc. Med.29,103-110.
18.
Saxen, I. (1975b). Etiological variables in oral clefts. Proceedings Finnish Dental Soc. Suppl. 3, 71.
19.
Shapiro, S., Heinonen, O.P., Siskind, V., Kaufman, D.W., Monson, R.R. & Slone, D. (1977). Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Bendectin) in relation to congenital malformations, perinatal mortality rate, birth weight and intelligence quotient score. Am. J. Obstet. Gynecol., 128, 480-485.
20.
Smithells, R.W. & Sheppard, S. (1978). Teratogenicity testing in humans: A method demonstrating safety of Bendectin. Teratology, 17, 31-36.
21.
Vivian, S.P. & Golding, J. (1981). Debendox in early pregnancy and fetal malformation . Brit. Med. J., 283, 725.
22.
Fraser, F.C. & Lytwyn, A. (1981). Spectrum of anomalies in the Meckel syndrome. Am. J. Med. Genet., 9, 67-73.
